News 2019 

Novo Nordisk UK prepared for all Brexit outcomes

Gatwick, April 11 2019 – As the biggest insulin supplier in the UK and with 95 years of innovation in diabetes care, Novo Nordisk is committed to ensuring patients’ medicine supplies are unaffected whatever the outcome of Brexit.






This page is intended for UK consumer media, UK trade/medical media and members of the UK public

UK19NNG00001  April 2019